Table 2 Comparison of cytological diagnosis of cervical lymphadenopathy between patients with and without HIV infection
Diagnosis | HIV positive patients(cases) | HIV negative patients(cases) | Total | P value | P value a |
|---|---|---|---|---|---|
Benign lesions | |||||
Reactive lymphoid hyperplasia | 131(28.9%) | 51(37.5%) | 182 | 0.058 | 0.232 |
Non-specific inflammation | 90(19.9%) | 26(19.1%) | 116 | 0.847 | 0.397 |
Suppurative lymphadenitis | 11(2.4%) | 8(5.9%) | 19 | 0.046 | 0.282 |
Granulomatous lymphadenitis | 5(1.1%) | 0 | 5 | 0.219 | 0.995 |
Kikuchi disease | 1(0.2%) | 1(0.7%) | 2 | 0.364 | 0.726 |
Opportunistic infections | 190(41.9%) | 17(12.5%) | 207 | 0.000 | < 0.001 |
Mycobacterial infection | 174(38.4%) | 17(12.5%) | 191 | 0.000 | < 0.001 |
Tuberculosis | 155(34.2%) | 17(12.5%) | 172 | 0.000 | < 0.001 |
Nontuberculous mycobacteria | 19(4.2%) | 0(4.2%) | 19 | 0.015 | 0.996 |
Cryptococcosis | 7(1.5%) | 0 | 7 | 0.145 | |
Talaromyces marneffei | 7(1.5%) | 0 | 7 | 0.145 | |
Other fungus | 2(0.4%) | 0 | 2 | 0.438 | |
Epidermal inclusion cyst | 2(0.4%) | 4(2.9%) | 6 | 0.011 | 0.008 |
Lipoma | 1(0.2%) | 0 | 1 | 0.583 | 0.994 |
Vascular lesions | 0 | 1(0.7%) | 1 | 0.068 | 0.993 |
Malignant lesions | |||||
lymphoma | 12(2.6%) | 9(6.6%) | 21 | 0.029 | 0.296 |
Hodgkin lymphoma | 1(0.2%) | 0 | 1 | 0.583 | |
Non Hodgkin lymphoma | 11(2.4%) | 9(6.6%) | 20 | 0.018 | 0.223 |
Kaposi’s sarcoma | 4(0.9%) | 0 | 4 | 0.272 | 0.996 |
Metastatic carcinoma | 3(0.7%) | 19(14%) | 22 | 0.000 | < 0.001 |
squamous cell carcinoma | 3(0.7%) | 12(8.8%) | 15 | 0.000 | 0.003 |
adenocarcinoma | 0 | 3(2.2%) | 3 | 0.002 | 0.993 |
small cell carcinoma | 0 | 3(2.2%) | 3 | 0.002 | 0.993 |
hepatocellular carcinoma | 0 | 1(0.7%) | 1 | 0.068 | |
Unsatisfactory aspirates | 3(0.7%) | 0 | 3 | 0.341 | 0.996 |
Total | 453 | 136 | 589 | – | |